J b chemicals and pharmaceuticals Limited has announced the record date for interim dividend eligibility for FY 2025-2026. The company has set February 11, 2026 as the cut-off date to determine which shareholders will be eligible to receive the interim dividend payment.

Record Date Details

The pharmaceutical company has fixed the record date in compliance with Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory requirement ensures transparency in determining dividend eligibility for shareholders.

Regulatory Compliance

The announcement was formally communicated to BSE Limited on February 5, 2026, through a regulatory filing. The communication was signed by Sandeep Phadnis, Vice President – Secretarial & Company Secretary of J.B. Chemicals & Pharmaceuticals Limited.

Shareholder Implications

Shareholders who hold equity shares of the company as of the record date will be entitled to receive the interim dividend for FY 2025-2026. The record date serves as the benchmark for determining beneficial ownership and dividend distribution eligibility. Investors planning to participate in the dividend distribution must ensure their shareholding is reflected in the company's records by February 11, 2026.

J.B. Chemicals & Pharmaceuticals Limited has officially relocated its registered office from Maharashtra to Gujarat, marking a significant corporate restructuring move. The Ministry of Corporate Affairs approved this transition on February 4, 2026, following the completion of all regulatory requirements.

Corporate Relocation Details

The pharmaceutical company has established its new registered office at a strategic location in Ahmedabad. The relocation process involved comprehensive regulatory compliance and formal approvals from multiple authorities.

Regulatory Compliance Process

The office relocation required substantial regulatory procedures under the Companies Act, 2013. The company passed a special resolution to alter provisions in its Memorandum of Association regarding the registered office location. This alteration was subsequently confirmed by Regional Director order bearing the date January 6, 2026.

The Certificate of Registration was issued under Section 13(5) of the Companies Act, 2013, by Sayali Gaikwad, Assistant Registrar of Companies at ROC Ahmedabad. The certification process transferred the company's jurisdiction from ROC Mumbai to ROC Ahmedabad.

Memorandum Amendment

Following the approved relocation, Clause II of the company's Memorandum of Association has been formally updated. The revised clause now states: "The registered office of the Company will be situated in the State of Gujarat."

This amendment reflects the company's commitment to establishing its legal domicile in Gujarat while continuing to maintain its corporate office operations at Energy IT Park, Unit A, 8th Floor, Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400 025.

Corporate Structure

The company operates under Corporate Identity Number L24390GJ1976PLC173077 and maintains dual operational presence across states. While the registered office has moved to Gujarat, J.B. Chemicals continues its corporate operations from Mumbai, ensuring business continuity and operational efficiency.

Sandeep Anil Phadnis, serving as Designated Company Secretary and Director, communicated this development to BSE Ltd. in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.